October 14, 2025

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating Biotech Opportunities with a $5.25 Billion Market Cap

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands as a notable player within the biotechnology sector, renowned for its dedication to addressing rare disorders through innovative therapies. With a market capitalization of..

LivaNova PLC (LIVN) Stock Analysis: Unveiling a 25% Potential Upside in the Innovative Medical Devices Sphere

LivaNova PLC (NASDAQ: LIVN), a medical technology powerhouse headquartered in London, is gaining traction among investors, boasting a significant potential upside of 25.34%. This intriguing figure, derived from an average..

Twist Bioscience Corporation (TWST) Stock Analysis: A 30.82% Upside Potential in the Synthetic DNA Market

Twist Bioscience Corporation (NASDAQ: TWST), a prominent player in the healthcare sector, specializing in diagnostics and research, is capturing the attention of investors with its innovative synthetic DNA-based products. The..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Unpacking a 29% Potential Upside for Savvy Investors

GoodRx Holdings, Inc. (NASDAQ: GDRX) is a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.45 billion, GoodRx stands out..

Phreesia, Inc. (PHR) Investor Outlook: Exploring a Promising 51.98% Upside with Strong Buy Ratings

For investors eyeing opportunities in the healthcare sector, Phreesia, Inc. (NYSE: PHR) presents a compelling proposition. With a market capitalization of $1.33 billion, this healthcare information services company is at..

Apellis Pharmaceuticals, Inc. (APLS)

⚠️ No article content returned.

..

SS Innovations International In (SSII)

⚠️ No article content returned.

..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Powerhouse with 33% Revenue Growth and Robust Buy Ratings

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a cutting-edge player in the biotechnology sector, has captured the attention of investors with its promising pipeline of peptide therapeutics targeting hematology, blood disorders, and..

Evotec SE (EVO) Stock Analysis: Exploring 37% Potential Upside Amidst Volatile Sector Dynamics

In the competitive landscape of the healthcare sector, Evotec SE (EVO) stands out as a dynamic player in the drug discovery and development arena. Headquartered in Hamburg, Germany, Evotec operates..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A 145% Potential Upside Sparks Investor Interest

Dyne Therapeutics, Inc. (NASDAQ: DYN), a promising player in the biotechnology sector, has been capturing the attention of investors with a compelling potential upside of 145.46%. As a clinical-stage company..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 20.83% Potential Upside in Healthcare Innovation

Guardian Pharmacy Services, Inc (GRDN) is a notable player in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Atlanta, Georgia, the company is renowned..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with Nearly 100% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector with its promising portfolio of therapeutic antibodies targeting severe inflammatory, allergic, and autoimmune diseases. Headquartered in Hampton, New..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A 145% Upside Potential Amidst Biotech Innovations

Investors with a keen eye on the biotechnology sector will find Edgewise Therapeutics, Inc. (NASDAQ: EWTX) a compelling prospect. With its focus on pioneering treatments for muscle disorders, Edgewise is..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A 198.93% Potential Upside in Biotech Breakthroughs

Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical innovator, is making waves in the biotechnology sector with its pioneering immunotherapy solutions. Headquartered in San Diego, California, this company is at..

Organon & Co. (OGN) Stock Analysis: Exploring a 37% Potential Upside in Healthcare Investments

In the ever-evolving landscape of healthcare investments, Organon & Co. (NYSE: OGN) presents a compelling opportunity for investors seeking exposure to the drug manufacturing sector. With its extensive portfolio focusing..

NovoCure Limited (NVCR): Investor Outlook on a Potential 103% Upside in the Medical Device Sector

NovoCure Limited (NASDAQ: NVCR), a Switzerland-based leader in the medical device industry, offers intriguing potential for investors looking to capitalize on its advancements in oncology. Specializing in innovative tumor treating..

Concentra Group Holdings (CON) Stock Analysis: Unlocking a 39.44% Potential Upside in Healthcare

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a leading provider of occupational health services in the United States, is catching the eye of investors with its robust growth potential and..

Structure Therapeutics Inc. (GPCR): Investor Outlook with a 142% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a trailblazer in the biotechnology sector, has been capturing investor attention with its innovative approach to addressing chronic diseases. The company’s focus on developing novel..

ImmunityBio, Inc. (IBRX): Investor Outlook with a 311% Potential Upside

For investors with an eye on the biotechnology sector, ImmunityBio, Inc. (NASDAQ: IBRX) presents a compelling narrative. With a market capitalization of $2.34 billion, the San Diego-based company is at..

Agios Pharmaceuticals (AGIO) Stock Analysis: Unveiling a 14% Upside Potential Amidst Robust Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its focus on groundbreaking treatments in the field of cellular metabolism. Based in Cambridge, Massachusetts, this biopharmaceutical..

Search

Funds

October 14, 2025

Search

Funds

October 14, 2025

FTSE 100

Funds